This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

United Therapeutics Corp (UTHR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 278.89M 154.03M 162.68M 252.16M
Receivables 126.30M 116.63M 88.68M 73.71M
Inventories 47.76M 37.25M 45.98M 35.52M
Other Current Assets 46.42M 20.83M 6.19M 6.84M
Total Current Assets 909.01M 668.47M 562.46M 764.49M
Property, Plant & Equipment, Gross 571.16M 531.68M 419.32M 344.24M
Accumulated Depreciation & Depletion 106.21M 77.99M 53.28M 38.19M
Property, Plant & Equipment, Net 464.95M 453.68M 366.05M 306.04M
Intangibles 3.41M 5.88M 13.96M 7.37M
Other Non-Current Assets 506.77M 337.88M 376.75M 149.11M
Total Non-Current Assets 1.18B 958.12M 955.62M 667.15M
Liabilities & Shareholder Equity
Total Assets 2.09B 1.63B 1.52B 1.43B
Accounts Payable 6.71M 10.20M 47.26M 16.15M
Short Term Debt 66.61M 0.00 0.00 0.00
Other Current Liabilities 312.97M 93.57M 108.09M 126.29M
Total Current Liabilities 687.67M 176.76M 212.58M 428.69M
Long Term Debt 3.72M 275.01M 194.18M 68.93M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 136.90M 90.85M 162.83M 50.13M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 140.62M 365.86M 357.01M 119.06M
Total Liabilities 828.29M 542.61M 569.59M 547.75M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.26B 1.08B 948.49M 883.89M
Common Par 630.00K 621.00K 615.00K 600.00K
Additional Paid In Capital 1.06B 1.02B 992.72M 928.69M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 728.04M 553.48M 249.04M 31.17M
Treasury Stock -513.44M -471.00M -283.00M -67.40M
Other Equity Adjustments -13.18M -14.96M -10.88M -9.18M
Total Capitalization 1.26B 1.36B 1.14B 952.82M
Total Equity 1.26B 1.08B 948.49M 883.89M
Total Liabilities & Stock Equity 2.09B 1.63B 1.52B 1.43B
Total Common Shares Outstanding 50.39M 50.17M 53.61M 57.56M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 12.63M 11.92M 7.90M 2.46M
Basic Weighted Shares Outstanding 50.08M 52.09M 57.16M 56.14M
Diluted Weighted Shares Outstanding 53.23M 53.28M 59.40M 59.52M
Number of Employees 706 623 543 520
Number of Part-Time Employees 0 0 0 0
UTHR News

UTHR United Therapeutics Corp

Analysts Ratings for UTHR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 5 4 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET UTHR ANALYST REPORT

Brokerage Partners

UTHR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs